Larvol Delta - VIRTUAL-A-phase-1-openLabel-single-ascending-dose-study-in-healthy-subjects-of-the-safety-tolerability-and-pharmacokinetics-of-ASLAN004-a-novel-IgG-antiIL13-receptor-alpha-1-Inhibitor

ASLAN004 - ASLAN

https://www.sidannualmeeting.org/wp-content/uploads/2021/05/SID-2021-Virtual-Meeting-LB-Abstract-Booklet-FINAL.pdf

L. Lee3; H. Hajireen2; A. Ward1; C. Firth1

May 4, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next